INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

GNPXGenprex, Inc.

CIK 0001595248

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells1 / 2
Max Insider Score33
Connections3with evidence

GNPX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
LM
Longnecker Brent MDirector
GNPXGenprex, Inc.
Open-market sale
SELL$9.84
8 sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Longnecker Brent MDirector · Apr 15, 2026
  • ← Disclosed trade inevidence
    Tim MoorePurchase disclosed 2026-02-20 · Feb 20, 2026
33
LM
Longnecker Brent MDirector
GNPXGenprex, Inc.
Open-market sale
SELL
$12.3
10 sh
Apr 14, 2026
Apr 15, 2026
traded Apr 14, 2026
+1d
SEC FORM 4

Evidence

24
Tim MooreRSelf
GNPXGenprex, Inc.
Purchase
BUY$1,001 – $15KFeb 5, 2026Feb 20, 2026
traded Feb 5, 2026
+15dHOUSE PTR

Evidence